Zynerba's cannabis based gel for epilepsy fails study

(Reuters) - Zynerba Pharmaceuticals said on Monday its experimental synthetic cannabis-based gel failed to induce a statistically significant reduction in seizures in a mid-stage study involving epilepsy patients.